RecruitingPhase 3NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Sponsor: Novartis Pharmaceuticals
Skokie, IL · Willowbrook, IL · +23 more sites
Lupus clinical trials in Skokie, IL
1 recruiting lupus studies with a site in Skokie, IL.
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.